Why the study?
Does clopidogrel monotherapy together with phenprocoumon provide similar pharmacodynamic safety compared to DAPT without a VKA in patients undergoing coronary stent implantation?
Does clopidogrel monotherapy together with phenprocoumon provide similar pharmacodynamic safety compared to DAPT without a VKA in patients undergoing coronary stent implantation?
Clopidogrel monotherapy combined with phenprocoumon shows similar pharmacodynamic effects to DAPT without a VKA after PCI, without increasing ischemic risk.
Answers are grounded in this paper and cite their sources.
May support clopidogrel monotherapy with phenprocoumon post-PCI in select cases; hypothesis-generating and requires randomized confirmation.
= 0.67). Following PCI, the pharmacodynamic effect of a clopidogrel monotherapy together with phenprocoumon is similar as compared to DAPT without a VKA, and not associated with an increased risk for ischemic events beyond the higher underlying baseline risk.
No takes yet. Share an insight, caveat, or question.
Valina et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: